These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24107632)

  • 1. SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways.
    Gubanova E; Issaeva N; Gokturk C; Djureinovic T; Helleday T
    Cell Cycle; 2013 Dec; 12(24):3770-80. PubMed ID: 24107632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells.
    Yun HJ; Hyun SK; Park JH; Kim BW; Kwon HJ
    Mol Cell Biochem; 2012 Apr; 363(1-2):281-9. PubMed ID: 22160829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate activation of cyclin-dependent kinases by the phosphatase Cdc25b results in premature mitotic entry and triggers a p53-dependent checkpoint.
    Varmeh S; Manfredi JJ
    J Biol Chem; 2009 Apr; 284(14):9475-88. PubMed ID: 19136558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells.
    Koledova Z; Kafkova LR; Krämer A; Divoky V
    Stem Cells; 2010 Mar; 28(3):450-61. PubMed ID: 20104581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk2 is required for p53-independent G2/M checkpoint control.
    Chung JH; Bunz F
    PLoS Genet; 2010 Feb; 6(2):e1000863. PubMed ID: 20195506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid destruction of human Cdc25A in response to DNA damage.
    Mailand N; Falck J; Lukas C; Syljuâsen RG; Welcker M; Bartek J; Lukas J
    Science; 2000 May; 288(5470):1425-9. PubMed ID: 10827953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI 3-kinase/Rac1 and ERK1/2 regulate FGF-2-mediated cell proliferation through phosphorylation of p27 at Ser10 by KIS and at Thr187 by Cdc25A/Cdk2.
    Lee JG; Kay EP
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):417-26. PubMed ID: 20811053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition.
    Ditano JP; Sakurikar N; Eastman A
    Cell Cycle; 2021 Jul; 20(13):1308-1319. PubMed ID: 34156324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
    Lo PK; Lee JS; Sukumar S
    Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint.
    Fukasawa T; Enomoto A; Miyagawa K
    Cell Signal; 2015 Aug; 27(8):1569-75. PubMed ID: 25936524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A.
    Sarkar S; Dey BK; Dutta A
    Mol Biol Cell; 2010 Jul; 21(13):2138-49. PubMed ID: 20462953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
    Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
    Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
    Sampath D; Shi Z; Plunkett W
    Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic suppression of the cell cycle gene CDC25A in tumor cells.
    Hammer S; To KK; Yoo YG; Koshiji M; Huang LE
    Cell Cycle; 2007 Aug; 6(15):1919-26. PubMed ID: 17671423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.
    Patsoukis N; Sari D; Boussiotis VA
    Cell Cycle; 2012 Dec; 11(23):4305-9. PubMed ID: 23032366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways.
    Gaul L; Mandl-Weber S; Baumann P; Emmerich B; Schmidmaier R
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):245-53. PubMed ID: 17653574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.